// App-Quantinova.ai

1789 : Peak Thrombin and D-Dimer Levels in Subjects with Severe Hemophilia Receiving Acute Treatment for Bleeding Episodes Experienced during Prophylactic Marstacimab Treatment

Researchers

Presenter

  • Satyaprakash Nayak

Principal Investigators

  • Sangeeta Raje

  • John Teeter

  • Lutz Harnisch

  • Steven Arkin

Medical Centers

  • Pfizer Inc., Cambridge, MA

  • Pfizer Inc, Collegeville, PA

  • Pfizer, Groton, CT

  • Evidera, Inc., London, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • D-dimer

Drug/Treatment

  • Prothrombin complex

  • FVIII

  • Evithrom

Outcome

  • N/A

Study Design

  • Dose Escalation

Phase

  • III

Study Id's

  • NCT02974855

  • NCT02531815

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved